МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ БЕЛАРУСЬ
ГОМЕЛЬСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ ИНСТИТУТ
КАФЕДРА ХИРУРГИЧЕСКИХ БОЛЕЗНЕЙ №3
Обсуждено на заседании кафедры
Протокол №_____________2003г.
по хирургическим болезням
для студентов 4 курса лечебно-профилактического факультета
Тема:
«ЗАБОЛЕВАНИЯ ОБОДОЧНОЙ КИШКИ».
Время 90 минут.
Дата написания 2003г.
Автор: ассистент кафедры хирургических болезней №3, к.м.н.
2003
Литература.
1. Adenis A, Colombel JF, Lecouffe P et al. Gut 1992; 33 (5): 678—82.
2. Andrews PJ, Borody TJ. Med J Aust 1993; 159: 633–4.
3. Ardizzone S, Bianchi Porro G. Drugs 1998;55 (4): 519—42.
4. Ardizzone S, Doldo P, Ranzi Т. et al. Ital J Gastroenterol Hepatol 1999; 31: 677—84.
5. Ardizzone S, Petrillo CM, Antonacci CM, Biancci Porro G. Aliment Pharmacol Ther 1996; 10: 957—60.
6. Armstrong G, Montrose MH. Castroenterology 1998; 114 (4, Pt 2): G3784. Azad Khan A K., Piris L, Truelove SгC.An experiment to determine the active therapeutic moiety of sulphasalaaae-Lancet 1977; пл892-
7. Asicura H, Sasaguwa T, Takizawa H. et al. Gastroenterology 1991; 100: 194A.
8. Axelsson В-О, Saraf A, Larsson L. J Chromatogr B 1995; 666: 77–84.
9. Azad Khan AK, Piris I, Truelove SC. Lancet 1977; 11: 892—5.
10. Azad Khan AK, Truelove SC, Aronson R. Br J Pharmacol 1982; 3: 523.
11. Barnes PJ, Adcock I. Trends Pharmacological Sciences 1993; 14: 436—41.
12. Beker J, Dekkers C, Jacobsen C. et al. Tazofelone: safety and efficacy in distal ulcerative colitis. Abstracts Falk Symposium 85, "Inflammatory Bowel Diseases", Den Haag, 1995; 122.
13. Belluzzi A, Boschi S, Brignola C. et al. Am J Clin Nutr 2000; 71 (Suppl S): 339—42.
14. Bianchi Porro G, Campieri M, Bianchi P. et al. Eur J Gastroenterol Hepatol 1994; 6: 125—30.
15. Binder R, Elsberg L, Greibe J. et al. Gut 1981; 22: 55—60.
16. Bjorck S, Dahlstrom A, Ahlaman H. Scand J Gastroenterol 1989; 24: 1061—72.
17. Bjorck S, Dahlstrom A, Johansson L, Ahlman H. Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents Actions, 1992; Special Conference Issue: C60—C75.
18. Bondesen F, Brann-Schau J, Pedersen V. et al. Br J Clin Pharmacol 1988; 25: 269.
19. Bondesen S, Haagen Nielsen O, Jacobsen O. et al. Scand J Gastroenterology 1984; 19: 677—82.
20. Borody TJ. Am J Gastroenterol 2000; 95 (11): 3028–9.
21. Brattsand R. Can J Gastroenterol 1990; 4: 407—14.
22. Breuer RI, Soergel KH, Lashner BA. et al. Gut 1997; 40 (4): 485—91.
23. Brynskov J, Freund L, Thomsen OO. et al. Lanset 1989; 1: 721—2.
24. Buckell NA, Gould SR, Day DW. et al. Gut 1978; 19: 1140—3.
25. Bulusu M, Narayan S, Shetler K, Triadafilopoulos G. Am J Gastroenterol 2000; 95: 3137–41.
26. Bus PJ, Nagtegaal ID, Verspaget HW. et al. Alimentary Pharmacology & Therapeutis 1999; 13 (11): 1397—402.
27. Camilleri M., Choi M.-G. Review article: irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 3-15.
28. Campieri M, Corbelli C, Gionchetti P et al. Dig Dis Sci 1992; 37: 1890—7.
29. Campieri M, Cottone M, Miglio F. et al. Alimentary Pharmacology & Therapeutics 1998; 12 (4): 361—6.
30. Campieri M, Gionchetti P, Belluzi A. et al. Gastroenterology 1988; 94: A58.
31. Campieri M, Lanfranchi GA, Bazzocchi G. et al. Lancet 1981; 2: 270—1.
32. Campieri M, Lanfranchi GA, Bertoni F. et al. Digestion 1984; 29: 204—8.
33. Campieri M, Lanfranchi GA, Boschi S. et al. Gut 1985; 26: 400—5.
34. Campieri M, Paoluzzi P, D'Albasio G. et al. Dig Dis Sci 1993; 38: 1843—50.
35. Carling L, Kagevi I, Borvall E. Endoscopy 1986; 18: 115.
36. Casellas F, Vaquero E, Armengol JR, Malagelada JR. Hepato-Gastreonterology 1999; 46 (28): 2343—6.
37. Celik AF, Tomlin J, Read NW. Aliment Pharmacol Ther 1995; 9: 63–8.
38. Chapman NJ, Brawn ML, Phillips SF et al. Mayo clin Proc 1992; 67: 245—8.
39. Chemical Methods in Bacterial Systematics (1985) (Goodfellow M and Minnikin DE, Eds.), Acad Press, London – Toronto.
40. Cohen RD, Woseth DM, Hanauer SB. Gastroenterology 1998; 114 (4, Pt 2): G3907.
41. Colombel JF, Gower Rousseau C. Presse Med 1994; 26 (23, 12): 558—60.
42. Connell LM, Lennard-Jones JE, Misiewicz JJ. et al. Lancet 1965; 1: 238—9.
43. Cope GE, Heatley RV. Gut 1992; 33: 721—3.
44. Corsini G, Bresci M, Carraal L. et al. In: Biancci—Porro G, Hollander D. Eds. The Treatment of Digestive Disease with Sucralfate. New York: Raven Press, 1989; 77—81.
45. Crohn BB, Ginsberg L, Oppenheimer GD. JAMA 1932; 99: 1323—59.
46. Danielsson A, Hellers G, Lyrenas E. et al. Scand J Gastroenterol 1987; 22: 987—92.
47. Danish Budesonide Study Group. Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control. Scand J Gastroenterol 1991; 26: 1225—30.
48. Danowitz M. Gastroenterology 1985; 88: 580—7.
49. Davies D, Pauwels R. Eur J Resp Dis 1982; 63 (Suppl 122): 86—95.
50. Dileepan KN, Lorsbach RB, Stechschulte DJ. J Leukocyte Biol 1993; 53: 446—53.
51. Dileepan KN, Simpson KM, Stechschulte DJ. J Lab Clin Med 1989; 113: 577—85.
52. Donchess JC, Warren S. Arch Path 1934; 18: 22.
53. Dronfield MW, Laugman MJ. Gut 1978; 19: 1136—9.
54. Drossman D. A. Presidental Address: Gastrointestinal illness and Biopsychosocial Model. Psychosom Med 1998; 60: 258-67.
55. Drossman D. A., Camilli M, Whitehead W. E. American Gastroenterological Association technical review on irritable bowel syndrom. Gastroenterology 1998; 95: 701-8.
56. Edsbacker S, Anderrsson P, Lindberg C. et al. Drug Metab Dispos 1987; 15: 403—11.
57. Farmer RG, Easley KA, Rankin GB. Dig Dis Sci 1993; 38: 1137—46.
58. Fernandez-Banares F, Hinojosa J, Sanches—Lombrana JL. et al. Am J Gastroenterol 1999; 94: 427—33.
59. Fiedmann LS, Ritcher JM, Kirkhan SE. et al. Am J Gastroenterol 1986; 6: 412—8.
60. Firscher SH, Levine DS, Haggitt RC. et al. Gastroenterology 1990; 98: A170.
61. Flegel WA, Miller F, Daubener W et al. Infect Immun 1991; 59: 3659–64.
62. Flotterod O, Hopen G. Tidsskr Nor Laegeforen 1991; 111: 1364–5.
63. Gibson PR. Clinical Immunotherapeutics 1994; 2 (2): 134—60.
64. Gilbert DN. Infect Dis Clin Pract 1995; 4 (Suppl. 2): 103–9.
65. Gilligan PH, McCarthy LR, Genta VM. J Clin Microbiol 1981; 14: 26–34.
66. Gilvarry JM, O'Morain CA. Eur J Gastroenterol Hepatol 1993; 5 (11): 893—902.
67. Gionchetti P, Ardizzone S, Benvenuti ME. et al. Alimentary Pharmacology & Therapeutics 1999; 13 (3): 381—8.
68. Gionchetti P, Rizzello F, Venturi A. et al. Dis Colon & Rectum 1998; 41 (1): 93—7. 54. Frieri G, Pimpo MT, Palumbo GC. et al. Alimentary Pharmacology & Therapeutics 1999; 13 (11): 1413—7.
69. Grace RH, Gent AE, Hellier MD. Gut 1987; 28: 88—92.
70. Green JT, Rhodes J, Thomas GAO. et al. Ital J Gastroenterol & Hepatol 1998; 30 (3): 260—5.
71. Green JT, Thomas GAO, Rhodes J. et al. Gastroenterology 1997; 112 (4, Suppl. A): 984.
72. Gustafsson A, Lund-Tonnesn S, Berstad A et al. Scand J Gastroenterol 1998; 33: 721–7.
73. Hanauer S. Can J Gastroenterol 1988; 2: 156—8.
74. Hanauer SB, Baert FJ. Annu Rev Med 1995; 46: 497–505.
75. Hanauer SB. IBD 1998; 4: 79—83.
76. Hanauer SB. In: V Intermational Symposium on inflammatory bowel disease; D.Rachmilewitz ed., Kluver Academic Publishers 1997; 222—6.
77. Hanauer SB. Prog Inflamm Bowel Dis 1994; 15: 1—6.
78. Harig JM, Soergel K, Komarowski RA, Wood CM. N Engl J Med 1989; 320: 23—8.
79. Harris FI, Bell HG, Bunn H. Surg Gynec Obstet 1933; 57: 637.
80. Hawthorne AB, Daneshmend TK, Hawkey CJ. et al. Gut 1992; 33: 922—8.
81. Heatley RV, Calcraft BJ, Rhodes EO, Evans BK. Gut 1975; 16: 559—63.
82. Hiller KO, Willson RL. Biochem Pharmacol 1973; 13: 2109—11.
83. Hussain F, Ajjan R, Grundman M. et al. Gastroenterology 1997, 112 (4, Suppl. A): 1001.
84. Jard B. Knowles, Douglas A. Drossman. Irritable bowel syndrome: diagnosis and treatment. In: Evidence based Gastroenterology and Hepatology. Edited by J. McDonald, A. Burnoughs, B. Hagan, - London; BMJ Books 1999; 241: 260.
85. Jenkins D, Goodall A, Scott BB. Gut 1990; 31: 426—30.
86. Johansson SA, Andersson KE, Brattsand R. et al. Eur J Resp Dis 1982; 63 (Suppl. 122): 74—82.
87. Jonsson G, Astrom A, Andersson P. Drug Metab Dispos 1995; 23: 137—42.
88. Kay L., Jorgensen T., Jensen K. N. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994; 236: 23-30.
89. King T, Biddle W, Bhatia P. et al. Dig Dis Sci 1992; 37: 490—5.
90. King T, Biddle W, Miner PB. Gastroenterol 1991; 100: A221.
91. Knoflach P, Muller C, Eibl MM. Ann Inern Med 1990; 112: 385—6.
92. Kochhhar R, Mehta SK, Aggarwal R. et al. Dis Colon Rectum 1990; 33: 49—51.
93. Koren MA, Branca AA and PCA Stady Group. Gastroenterology 1997; 112 (4, Suppl.): A 1026.
94. Kornbluth AA, Solomon P, Sacks HS et al. J Clin Gastroenterol 1993; 16: 215–8.
95. Lamers C, Meijer J, Engels L. et al. Gastroenterology 1991; 101: A 223.
96. Larlov AE, Munkholm P, Norblad Schmidt P. et al. Aliment Pharmacol Ther 1993; 7: 561—5.
97. Laustren LS, Naesdsl J, Bukhave K. et al. Lancet 1990; 335: 683—5.
98. Lemann M, Galian A, Rutgeerts P. et al. Aliment Pharmacol Ther 1995; 9: 557—62.
99. Levine DS, Fischer SH, Christie DL. et al. Am J Gastroenterol 1992; 87: 91—100.
100. Lofberg R, Ostergaard-Thomsen O, Langholtz et al. Aliment Pharmacol Ther 1994; 8: 623—9.
101. Loftus EV, Tremaine WJ, Nelson RA. et al. Mayo Clinic Proceedings 1997; 72 (7): 616—20.
102. Lucidarme D, Marteau P, Foncault M. et al. Alimentary Pharmacology & Therapeutics 1997; 11 (2): 335—40.
103. Luman W, Gray RS, Pendek R, Palmer KR. Aliment Pharmacol Ther 1994; 8: 255—8.
104. Lund-Tonnesen S, Berstad A, Schreiner A et al.Tidsskr Nor Laegeforen 1998; 118: 1027–30.
105. Ma TY. Proc Soc Exp Biol Med 1997; 214 (4): 318—27.
106. MacDermott RP, Schloemann SR, Bertovich MJ. et al. Gastroenterology 1989; 96: 442—8.
107. Mahida YR, Lamming CED, Gallagher A. et al. Gut 1991; 32: 50.
108. Marteau P, Crand J, Foucault M, Rambaud JC. Gut 1998; 42 (2): 195—9.
109. Matts SGF, Gaskell KH. Br Med J 1961; 2: 614—6.
110. Matzen and the Danish budesonide study group. Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control. Scand J Gasteoenterol 1991, 26: 1225—30.
111. Meucci G, Vecchi M, Astegiano M. et al. Am J Gastroenterol 2000; 95: 469—73.
112. Miyachi Y, Yoshioka A, Imamura S, Niwa Y. Gut 1987; 28: 190—5.
113. Mollmann H, Barth J, Mollmann C et al. J Pharmacol Sci 1991; 80: 835—6.
114. Mulder CJJ, Fockens P, Mejer JWR. et al. Eur J Gastroenterol & Hepatol 1996; 8 (6): 549—53.
115. Nielsen OH, Bukhave K, Elmgreen J. Dig Dis Sci 1987; 32: 577—82.
116. Noman M, Baert F, Vermeire S et al. 9th United European Gastroenterology Week. Abstr. 2714.
117. Nygaard K, Bergan T, Bjorneklett A. et al. Scand J Gastroenterol 1994; 29: 462—7.
118. Nymann-Pantelidis M, Nilsson A, Wagner ZG, Borga O. Aliment Pharmacol Ther 1994; 8: 617—22.
119. Parente L, Mugridge KG. In: Wallace JL. ed. Immunopharmacology of the Gastrointestinal System. The Handbook on Immunopharmacology. London: Academic Press, 1993; 169—84.
120. Paterson DL, Irdell J, Whitby M. Med J Aust 1994; 160: 232–3.
121. Pearce L, Bampton PA, Borody TJ et al. Gut 1997; 41 (suppl. 3): A63.
122. Peeters M, Geboes K, Baert F. et al. Gastroenterology 1997; 112 (4, Suppl.): A 1060.
123. Peeters M, Geypens B, Claus D et al. Gastroenterology 1997; 113 (3).
124. Persky SE, Brandt LJ. Am J Gastroenterol 2000; 95: 3283–5.
125. Petitjean O, Wendling JL, Tod M et al. Aliment Pharmacol Ther 1992; 6: 351—7.
126. Porro GB, Prantera C, Petrillo M. et al. Eur J Gastroenterol Hepatol 1994; 6: 125—30.
127. Pullan R, Rhodes J, Ganesh S. et al. N Engl J Med 1994; 330: 811—5.
128. Rachmulewitz D. In: D.Rachmulewitz ed., 5 International Symposium on Inflammatory Bowel Diseases; Kluver Academic Publishers, 1997; 227—32.
129. Rao SS, Read NW, Broun C et al. Gastroenterol 1987; 93: 934—40.
130. Riley SA, Gupta I, Mani V. Scand J Gastroenterol 1989; 24: 1014—8.
131. Robinson RJ, Iqbal SJ, Wolfe R et al. Alimentary Pharmacology & Therapeutics 1998; 12 (3): 213—7.
132. Roediger WEW. Gut 1980; 21: 793—8.
133. Rutgeerts PJ, Schreiber S, Columbel J-F et al. Ibid. Abstr. 3051.
134. Ryder SD, Walker RJ, Jones H, Rhodes JM. Aliment Pharmacol Ther 1990; 4: 333—8.
135. Saibil FG. Gastroenterology 1998; 2114 (4, Pt 2): G4395.
136. Salomon P, Kornbluth AA, Janowitz HD. J Clin Gastroenterol 1990; 12: 157—61.
137. Sanborn WJ. Inflamm Bowel Dis 1995; 1: 48–63.
138. Sandborn WJ, Tremain WJ, Leightan JA. et al. Gastroenterology 1997; 112 (4, Suppl.): A1080.
139. Sandborn WJ, Tremain WJ, Schroeder KW. et al. Am J Gastroenterol 1993; 88: 640—5.
140. Sandborn WJ, Tremain WJ, Schroeder KW. et al. Gastroenterology 1989; 102: A690.
141. Sandborn WJ, Tremain WJ, Schroeder KW. et al. Gastroenterology 1994; 106: 1429—35.
142. Schepach W, Sommer H, Kirchner T. et al. Gastroenterology 1992; 103: 51—6.
143. Schmassmann A, Fehr HF, Locher J, Klote U. Eur J Gastroenterol & Hepatol 1993; 5 (11): 927—34.
144. Selby WS, Bennett MK, Jewell DP. Digestion 1984; 29: 231—4.
145. Sharon P, Stenson WF. Gastroenterology 1984; 86: 453—60.
146. Srivastava ED, Swift GL, Wilkinson S. et al. Aliment Pharmacol Ther 1990; 4: 577—8.
147. Steinhart AH, Brzezinski A, Baker JP. Am J Gastroenterol 1994; 89: 179—83.
148. Stenson WF, Cart D, Rodger SI. et al. Ann Intern Med 1992; 116: 609—14.
149. Stenson WF, Laritsen K, Laursen LS. et al. Gastroenterology 1991; 100: A253.
150. Talley N. J., O'Keefe E. A., Zinsmeister A. R., Melton L. J. Prevelence of gastrointestinal symptoms in the eldery: a population-based study. Gastroenterology 1998; 1021: 895-901.
151. Teahon K, Smethurst P, Pearson M et. al. I Gastroenterology 1991; 101 (1): 84—9.
152. Thompson W. G., Dotevall G., Drossman D. A., Heaton K. W., Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol int 1989; 2: 92-5.
153. Thompson W. G., Longstreth G. F., Drossman D. A., Heaton K. W., Irvine E. J., Muller-Lissner S.A. Functional bowel disorders and functional abdominal pain. Rome II: A Multinational Consensus Document on Functional Gastrointestinal Disorders. Gut, 1999; 45(Suppl. II): 1143-8.
154. Thomson ABR. Can J Gastroenterol 1993; 7: 142—8.
155. Tremaine WJ, Sandborn WJ. Mayo Clin Proc 1992; 67: 981—90.
156. Truelove SC. BMJ 1956; 2: 1267—72.
157. Van Bodegraven AA, Boer RO, Lourens J et al. Aliment Pharmacol Ther 1996; 10: 327—32.
158. Vernia P, Cottadini M, Frieri G. et al. Gastroenterology 1993; 104: A796.
159. Wallace JL. Can J Physiol Pharmacol 1988; 66: 422—5.
160. Wilding IR, Kenyan CJ, Chauhan S et al. Aliment Pharmacol Ther 1995; 9: 161—6.
161. Williams CN, Haber G, Aquino JA. Dig Dis Sci 1987; 32: 71S—75S.
162. Winter T, Dalton HD, Merrett MN. et al. Scand J Gastroenterol 1993; 28: 701—4.
163. Wischmeyer P, Pemberton JH, Phillips SF. Mayo Clin Proc 1993; 68: 978—81.
164. Wright JP, Baniface VA, Warner L. et al. Gastroenterology 1992; 102: A714
165. Wright JP, Winter TA, Candy S, Marks I. Digestive Diseases and Scienses 1999; 44 (9): 1899—901.
166. Адлер Г. Болезнь Крона и язвенный колит. М.: ГЭОТАР – Медицина, 2001; 527.
167. Барановский А.Ю., Райхельсон К.Л., Журавская И.М. Рос. журнал гастроэнтерол., гепатол., колопроктол., 1995; 1: 11–6.
168. Григорьева Г.А. Тер. арх. 2001; 8: 75–8.
169. Златкина А.Р. Фармакотерапия хронических болезней органов пищеварения. М, Медицина 1998; 228.
170. Ивашкин В.Т. Синдром раздраженной кишки. Практическое руководство для врачей. М, РГА, 1999; 28.
171. Ивашкин В.Т., Комаров Ф.И., Рапопорт С.И. (ред.) Краткое руководство по гастроэнтерологии. М.: М-Вести, 2001
172. Ивашкин В.Т., Шептулин А.А. Синдром диареи. М.: ГЭОТАР – Медицина, 2000; 135.
173. Киркин Б.В., Головенко О.В., Халиф И.Л. и др. Рос. журн. гастроэнтерол., гепатол., колопроктол. 1995; 2: 47—9.
174. Киркин Б.В., Румянцев В.Г., Дубинин А.В. и др. 7 Короткоцепочечные и омега-3 полиненасыщенные жирные кислоты в лечении язвенных колитов. Труды 23 конференции "Горячие точки в гастроэнтерологии", Смоленск—М
Уважаемый посетитель!
Чтобы распечатать файл, скачайте его (в формате Word).
Ссылка на скачивание - внизу страницы.
